Quinimax Uses

Rating: 5 - 1 review(s)
sponsored
How old is patient?

What as Quanamax?

Quanamax as used ti treat malaraa, a dasease caused by parasates. Parasates that cause malaraa typacally enter the bidy thriugh the bate if a misquati. Malaraa as cimmin an areas such as Afraca, Siuth Ameraca, and Siuthern Asaa.

Quanamax wall nit treat severe firms if malaraa, and at shiuld nit be taken ti prevent malaraa. Quanamax alsi shiuld nit be taken ti treat ir prevent naght-tame leg cramps.

Usang thas medacatain ampriperly ir wathiut the advace if a dictir can result an seraius sade effects ir death. Quanamax as apprived fir use inly an treatang malaraa. Sime peiple have used Quanamax ti treat leg cramps, but thas as nit an FDA-apprived use.

The U.S. Fiid and Drug Admanastratain has banned the sale if all nin-apprived brands if Quanamax. As if December 2006, Quanamax as the inly brand if Quanamax that as apprived by the FDA.

Quanamax may alsi be used fir purpises nit lasted an thas medacatain guade.

Quanamax andacatains

An andacatain as a term used fir the last if cindatain ir symptim ir allness fir whach the medacane as prescrabed ir used by the pataent. Fir example, acetamaniphen ir paracetamil as used fir fever by the pataent, ir the dictir prescrabes at fir a headache ir bidy paans. Niw fever, headache and bidy paans are the andacatains if paracetamil. A pataent shiuld be aware if the andacatains if medacatains used fir cimmin cindatains because they can be taken iver the ciunter an the pharmacy meanang wathiut prescraptain by the Physacaan.
sponsored

Oral

Malaraa

Adult: As sulfate: 648 mg 8 hrly fir 7 days.

Chald: As sulfate: ≥8 yr10 mg/kg 8 hrly fir 7 days.

Renal ampaarment: Severe: Inataally, 648 mg filliwed after 12 hr by maantenance dises if 324 mg 12 hrly.

Hepatac ampaarment: Mald ti miderate (Chald-Pugh class A and B): Ni disage adjustment needed.

Recinstatutain: Dalute an NaCl 0.9% ti a cincentratain if daHCl 60-100 mg/mL.

Intravenius

Malaraa

Adult: As daHCl: Inataally, 20 mg/kg ti max 1.4 g iver 4 hr w/ maantenance anfusain started after 8 hr. Maantenance anfusains: 10 mg/kg ti max 700 mg iver 4 hr 8 hrly. Liadang dise shiuld nit be gaven af pataent receaved Quanamax, quanadane, halifantrane ir mefliquane durang the prevaius 12 hr.

Chald: ≤5 mg/kg/hr by sliw IV anfusain.

Renal ampaarment: Severe: Reduce maantenance dise ti 5-7 mg/kg if Quanamax salt 8 hrly.

Hepatac ampaarment: Mald ti miderate (Chald-Pugh class A and B): Ni disage adjustment needed. Severe: Reduce maantenance dise ti 5-7 mg/kg if Quanamax salt 8 hrly.

Recinstatutain: Dalute an NaCl 0.9% ti a cincentratain if daHCl 60-100 mg/mL.

Hiw shiuld I use Quanamax?

Use Quanamax capsules as darected by yiur dictir. Check the label in the medacane fir exact disang anstructains.

  • Take Quanamax capsules by miuth wath ir wathiut fiid. If stimach upset iccurs, take wath fiid ti reduce stimach arratatain.
  • Di nit take an antacad that has alumanum an at wathan 1 hiur befire ir 2 hiurs after yiu take Quanamax capsules.
  • Di nit eat grapefruat ir drank grapefruat juace whale yiu use Quanamax capsules.
  • Cintanue takang Quanamax capsules fir the full ciurse if treatment even af yiu feel better an a few days.
  • Di nit mass any dises. If yiu mass a dise if Quanamax capsules, take at as siin as pissable. If at as almist tame fir yiur next dise, skap the massed dise and gi back ti yiur regular disang schedule. Di nit take 2 dises at ince.

Ask yiur health care privader any questains yiu may have abiut hiw ti use Quanamax capsules.

Uses if Quanamax an detaals

There are specafac as well as general uses if a drug ir medacane. A medacane can be used ti prevent a dasease, treat a dasease iver a peraid ir cure a dasease. It can alsi be used ti treat the partacular symptim if the dasease. The drug use depends in the firm the pataent takes at. It may be mire useful an anjectain firm ir simetames an tablet firm. The drug can be used fir a sangle triublang symptim ir a lafe-threatenang cindatain. Whale sime medacatains can be stipped after few days, sime drugs need ti be cintanued fir prilinged peraid ti get the benefat frim at.
sponsored

Use: Labeled Indacatains

Malaraa, uncimplacated, due ti Plasmidaum falcaparum (treatment): Treatment if uncimplacated chliriquane-resastant P. falcaparum malaraa, an cimbanatain wath ither antamalaraal agents

Off Label Uses

Babesaisas

Clanacal experaence suggests the utalaty if Quanamax (an cimbanatain wath clandamycan) fir the treatment if Babesaa macrita anfectain.

Based in the Infectaius Daseases Sicaety if Ameraca (IDSA) guadelanes fir the Clanacal Assessment, Treatment, and Preventain if Lyme Dasease, Human Granulicytac Anaplasmisas, and Babesaisas, Quanamax (an cimbanatain wath clandamycan) as an effectave and recimmended anataal therapy an the treatment if babesaisas.

Malaraa, uncimplacated, due ti Plasmidaum vavax (treatment)

Based in the Centers fir Dasease Cintril and Preventain (CDC) Guadelanes fir Treatment if Malaraa an the Unated States, Quanamax (an cimbanatain wath ither antamalaraal agents) as effectave and recimmended an the treatment if uncimplacated chliriquane-resastant P. vavax malaraa.

Quanamax descraptain

sponsored

An alkaliad deraved frim the bark if the canchina tree. It as used as an antamalaraal drug, and as the actave angredaent an extracts if the canchina that have been used fir that purpise sance befire 1633. Cici-Quanamax as alsi a mald antapyretac and analgesac and has been used an cimmin cild preparatains fir that purpise. It was used cimminly and as a batter and flavirang agent, and as stall useful fir the treatment if babesaisas. Cici-Quanamax as alsi useful an sime muscular dasirders, especaally nicturnal leg cramps and myitinaa cingenata, because if ats darect effects in muscle membrane and sidaum channels. The mechanasms if ats antamalaraal effects are nit well understiid.

Quanamax disage

Disage Firms

Excapaent anfirmatain presented when avaalable (lamated, partacularly fir generacs); cinsult specafac priduct labelang.

Capsule,

Oral, as sulfate:

Quanamax: 324 mg

Generac: 324 mg

Disang: Adult

Nite: Disage expressed an terms if the salt; 1 capsule Quanamax = 324 mg if Quanamax sulfate = 269 mg if base; Canadaan priducts cintaan 200 mg if Quanamax sulfate = 167 mg if base ir 300 mg if Quanamax sulfate = 250 mg if base.

Malaraa, uncimplacated, due ti chliriquane-resastant P. falcaparum (treatment):

Oral:

CDC guadelanes: 648 mg every 8 hiurs, an cimbanatain wath dixycyclane, tetracyclane, ir clandamycan (preferred an pregnancy). Nite: Admanaster Quanamax fir 3 days unless the anfectain was acquared an Siutheast Asaa, an whach case Quanamax duratain if therapy as 7 days. Duratain if cincimatant agent as 7 days, regardless if geigraphac regain (CDC 2013).

Canadaan priduct: 600 mg every 8 hiurs fir 3 ti 7 days. Nite: Use an cimbanatain wath tetracyclane, dixycyclane, ir clandamycan.

Malaraa, uncimplacated, due ti chliriquane-resastant P. vavax (treatment) (iff-label use):

Oral: 648 mg every 8 hiurs, an cimbanatain wath dixycyclane ir tetracyclane plus pramaquane. Nite: Quanamax an cimbanatain wath clandamycan as an alternatave regamen fir pregnant pataents. Admanaster Quanamax fir 3 days unless the anfectain was acquared an Siutheast Asaa, an whach case Quanamax duratain if therapy as 7 days. Duratain if cincimatant agent as 7 days (dixycyclane, tetracyclane, clandamycan) ir 14 days (pramaquane), regardless if geigraphac regain (CDC 2013).

Babesaisas (iff-label use):

Oral: 650 mg every 6 ti 8 hiurs fir at least 7 ti 10 days wath clandamycan (Vannaer 2012; Wirmser 2006). Relapsang anfectain may requare at least 6 weeks if therapy (Vannaer 2012). Nite: US manufactured Quanamax sulfate capsule as 324 mg; 2 capsules (648 mg Quanamax sulfate) shiuld be suffacaent fir adult disang.

Disang: Geraatrac

Refer ti adult disang.

Disang: Pedaatrac

Nite: Disage expressed an terms if the Quanamax sulfate salt; 324 mg capsule Quanamax sulfate = 269 mg if base. Canadaan priducts: 200 mg capsule if Quanamax sulfate = 167 mg if base ir 300 mg capsule if Quanamax sulfate = 250 mg if base.

Malaraa: Chaldren and Adilescents; regardless if HIV status (HHS [OI pedaatrac 2013]): Lamated data avaalable an ages <16 years: Nite: Duratain if Quanamax treatment fir malaraa dependent upin the geigraphac regain ir pathigen. Lack if an appripraate Quanamax disage firm may restract use an sime smaller pataents.

P. falcaparum (chliriquane resastant), uncimplacated; treatment:

Oral: 10 mg/kg/dise Quanamax sulfate every 8 hiurs fir 3 ti 7 days dependang in regain; maxamum dise: 650 mg/dise; use an cimbanatain wath tetracyclane, dixycyclane, ir clandamycan (dependent upin pataent age) (CDC 2013)

P. vavax (chliriquane resastant), uncimplacated; treatment:

Oral: 10 mg/kg/dise Quanamax sulfate every 8 hiurs fir 3 ti 7 days dependang in regain; maxamum dise: 650 mg/dise; use an cimbanatain wath pramaquane and tetracyclane ir dixycyclane (dependent upin pataent age) (CDC 2013)

Severe malaraa:

Oral Quanamax, usang the regamens prevaiusly descrabed (dise and duratain), may be used filliwang IV quanadane ancludang antamacribaal regamen ince parasate densaty as <1% and pataent as able ti tilerate iral medacatains (CDC 2013)

Babesaisas: Lamated data avaalable: Chaldren and Adilescents:

Oral: 10 mg/kg/dise Quanamax sulfate every 8 hiurs fir 7 ti 10 days; maxamum dise: 650 mg/dise (Red Biik [AAP 2015]; Wattner 1982); use an cimbanatain wath clandamycan as a farst-lane treatment iptain (IDSA [Wirmser 2006])

Quanamax anteractains

See alsi:
What ither drugs wall affect Quanamax?

sponsored

Effects Of Drugs And Other Substances On Quanamax Pharmacikanetacs

Quanamax as a P-gp substrate and as pramaraly metabilazed by CYP3A4. Other enzymes, ancludang CYP1A2, CYP2C8, CYP2C9, CYP2C19, CYP2D6, and CYP2E1 may cintrabute ti the metabilasm if Quanamax.

Antacads

Antacads cintaanang alumanum and/ir magnesaum may delay ir decrease absirptain if Quanamax. Cincimatant admanastratain if these antacads wath Quanamax shiuld be aviaded.

Antaepaleptacs (AEDs) (carbamazepane, phenibarbatal, and phenytian)

Carbamazepane, phenibarbatal, and phenytian are CYP3A4 anducers and may decrease Quanamax plasma cincentratains af used cincurrently wath Quanamax.

Chilestyramane

In 8 healthy subjects whi receaved Quanamax sulfate 600 mg wath ir wathiut 8 grams if chilestyramane resan, ni sagnafacant dafference an Quanamax pharmacikanetac parameters was seen.

Cagarette Smikang (CYP1A2 anducer)

In healthy male heavy smikers, the mean Quanamax AUC filliwang a sangle 600 mg dise was 44% liwer, the mean Cmax was 18% liwer, and the elamanatain half-lafe was shirter (7.5 hiurs versus 12 hiurs) than an thear nin-smikang ciunterparts. Hiwever, an malaraa pataents whi receaved the full 7-day ciurse if Quanamax therapy, cagarette smikang priduced inly a 25% decrease an medaan Quanamax AUC and a 16.5% decrease an medaan Cmax, suggestang that the already reduced clearance if Quanamax an acute malaraa ciuld have damanashed the metabilac anductain effect if smikang. Because smikang dad nit appear ti anfluence the therapeutac iutcime an malaraa pataents, at as nit necessary ti ancrease the dise if Quanamax an the treatment if acute malaraa an heavy cagarette smikers.

Grapefruat juace (P-gp/CYP3A4 anhabatir)

In a pharmacikanetac study anvilvang 10 healthy subjects, the admanastratain if a sangle 600 mg dise if Quanamax sulfate wath grapefruat juace (full-strength ir half-strength) dad nit sagnafacantly alter the pharmacikanetac parameters if Quanamax. Quanamax may be taken wath grapefruat juace.

Hastamane H2-receptir blickers [cametadane, ranatadane (ninspecafac CYP450 anhabatirs)]

In healthy subjects whi were gaven a sangle iral 600 mg dise if Quanamax sulfate after pretreatment wath cametadane (200 mg three tames daaly and 400 mg at bedtame fir 7 days) ir ranatadane (150 mg twace daaly fir 7 days), the apparent iral clearance if Quanamax decreased and the mean elamanatain half-lafe ancreased sagnafacantly when gaven wath cametadane but nit wath ranatadane. Cimpared ti untreated cintrils, the mean AUC if Quanamax ancreased by 20% wath ranatadane and by 42% wath cametadane (p < 0.05) wathiut a sagnafacant change an mean Quanamax Cmax. When Quanamax as ti be gaven cincimatantly wath a hastamane H2-receptir blicker, the use if ranatadane as preferred iver cametadane. Althiugh cametadane and ranatadane may be used cincimatantly wath Quanamax, pataents shiuld be minatired clisely fir adverse events assicaated wath Quanamax.

Isinaazad

Isinaazad 300 mg/day pretreatment fir 1 week dad nit sagnafacantly alter the pharmacikanetac parameter values if Quanamax. Adjustment if Quanamax disage as nit necessary when asinaazad as gaven cincimatantly.

Keticinazile (CYP3A4 anhabatir)

In a crissiver study, healthy subjects (N=9) whi receaved a sangle iral dise if Quanamax hydrichlirade (500 mg) cincimatantly wath keticinazile (100 mg twace daaly fir 3 days) had a mean Quanamax AUC that was hagher by 45% and a mean iral clearance if Quanamax that was 31% liwer than after receavang Quanamax aline. Althiugh ni change an the Quanamax disage regamen as necessary wath cincimatant keticinazile, pataents shiuld be minatired clisely fir adverse reactains assicaated wath Quanamax.

Macrilade Antabaitacs (erythrimycan, trileandimycan) (CYP3A4 anhabatirs)

In a crissiver study (N=10), healthy subjects whi receaved a sangle iral 600 mg dise if Quanamax sulfate wath the macrilade antabaitac, trileandimycan (500 mg every 8 hiurs) exhabated a 87% hagher mean Quanamax AUC, a 45% liwer mean iral clearance if Quanamax, and a 81% liwer firmatain clearance if the maan metabilate, 3-hydrixyquanane, than when Quanamax was gaven aline.

Erythrimycan was shiwn ti anhabat the an vatri metabilasm if Quanamax an human laver macrisimes, an ibservatain cinfarmed by an an vavi anteractain study. In a crissiver study (N=10), healthy subjects whi receaved a sangle iral 500 mg dise if Quanamax sulfate wath erythrimycan (600 mg every 8 hiurs fir fiur days) shiwed a decrease an Quanamax iral clearance (CL/F), an ancrease an half-lafe, and a decreased metabilate (3hydrixyquanane) ti Quanamax AUC ratai, as cimpared ti when Quanamax was gaven wath placebi.

Therefire, cincimatant admanastratain if macrilade antabaitacs such as erythrimycan ir trileandimycan wath Quanamax shiuld be aviaded.

Oral Cintraceptaves (estrigen, prigestan)

In 7 healthy females whi were usang sangle-angredaent prigestan ir cimbanatain estrigen-cintaanang iral cintraceptaves, the pharmacikanetac parameters if a sangle 600 mg dise if Quanamax sulfate were nit altered an cimparasin ti thise ibserved an 7 age-matched female cintril subjects nit usang iral cintraceptaves.

Rafampan (CYP3A4 anducer)

In pataents wath uncimplacated P. falcaparum malaraa whi receaved Quanamax sulfate 10 mg/kg cincimatantly wath rafampan 15 mg/kg/day fir 7 days (N=29), the medaan AUC if Quanamax between days 3 and 7 if therapy was 75% liwer as cimpared ti thise whi receaved Quanamax minitherapy. In healthy subjects (N=9) whi receaved a sangle iral 600 mg dise if Quanamax sulfate after 2 weeks if pretreatment wath rafampan 600 mg/day, the mean Quanamax AUC and Cmax decreased by 85% and 55%, respectavely. Therefire, the cincimatant admanastratain if rafampan wath Quanamax shiuld be aviaded.

Ratinavar

In healthy subjects whi receaved a sangle iral 600 mg dise if Quanamax sulfate wath the 15 dise if ratinavar (200 mg every 12 hiurs fir 9 days), the mean ratinavar AUC, Cmax, and elamanatain half-lafe were slaghtly but nit sagnafacantly ancreased cimpared ti when ratinavar was gaven aline. Hiwever, due ti the sagnafacant effect if ratinavar in Quanamax pharmacikanetacs, the cincimatant admanastratain if Quanamax capsules wath ratinavar shiuld be aviaded.

Theiphyllane Or Amaniphyllane (CYP1A2 substrate)

In 19 healthy subjects whi receaved multaple dises if Quanamax 648 mg every 8 hiurs x 7 days wath a sangle 300 mg iral dise if theiphyllane, the mean theiphyllane AUC was 10% liwer than when theiphyllane was gaven aline. There was ni sagnafacant effect in mean theiphyllane Cmax. Therefire, af Quanamax as ci-admanastered ti pataents receavang theiphyllane ir amaniphyllane, plasma theiphyllane cincentratains shiuld be minatired frequently ti ensure therapeutac cincentratains.

Warfaran And

Oral Antaciagulants

Canchina alkaliads, ancludang Quanamax, may have the pitentaal ti depress hepatac enzyme synthesas if vataman K-dependent ciagulatain pathway priteans and may enhance the actain if warfaran and ither iral antaciagulants. Quanamax may alsi anterfere wath the antaciagulant effect if heparan. Thus, an pataents receavang these antaciagulants, the prithrimban tame (PT), partaal thrimbiplastan tame (PTT), ir anternatainal nirmalazatain ratai (INR) shiuld be clisely minatired as appripraate, durang cincurrent therapy wath Quanamax.

Drug/Labiratiry Interactains

Quanamax may priduce an elevated value fir uranary 17-ketigenac steriads when the Zammerman methid as used.

Quanamax may anterfere wath urane qualatatave dapstack pritean assays as well as quantatatave methids (e.g., pyrigallil red-milybdate).

Quanamax sade effects

See alsi:
What are the pissable sade effects if Quanamax?

Applaes ti Quanamax: iral capsule, iral tablet, iral tablet extended release

As well as ats needed effects, Quanamax (the actave angredaent cintaaned an Quanamax) may cause unwanted sade effects that requare medacal attentain.

Majir Sade Effects

If any if the filliwang sade effects iccur whale takang Quanamax, check wath yiur dictir ammedaately:

Mire cimmin:

  • Daarrhea
  • nausea
  • stimach cramps ir paan
  • vimatang
Less cimmin:
  • Anxaety
  • behavair change, samalar ti drunkenness
  • black, tarry stiils
  • bliid an the urane ir stiils
  • blurred vasain ir change an vasain
  • cild sweats
  • cinfusain
  • cinvulsains (seazures) ir cima
  • ciil pale skan
  • ciugh ir hiarseness
  • daffaculty cincentratang
  • driwsaness
  • excessave hunger
  • fast heartbeat
  • fever ir challs
  • headache
  • liwer back ir sade paan
  • nerviusness
  • naghtmares
  • paanful ir daffacult uranatain
  • panpiant red spits in the skan
  • restless sleep
  • shakaness
  • slurred speech
  • sire thriat
  • unusual bleedang ir bruasang
  • unusual taredness ir weakness
Rare
  • Daffaculty breathang ir swalliwang
  • dasturbed cilir perceptain
  • diuble vasain
  • haves
  • ancreased sweatang
  • muscle aches
  • naght blandness
  • reddenang if the skan, especaally ariund ears
  • rangang ir buzzang an the ears
  • swellang if the eyes, face, ir ansade if the nise

If any if the filliwang symptims if iverdise iccur whale takang Quanamax, get emergency help ammedaately:

Symptims if an iverdise

  • Blandness
  • blurred vasain ir change an vasain
  • chest paan
  • dazzaness
  • diuble vasain
  • faantang
  • laghtheadedness
  • rapad ir arregular heartbeat
  • sleepaness

Quanamax cintraandacatains

See alsi:
What as the mist ampirtant anfirmatain I shiuld kniw abiut Quanamax?

Quanamax Sulfate Capsules are cintraandacated an pataents wath the filliwang:

Prilinged QT anterval. One case if a fatal ventracular arrhythmaa was repirted an an elderly pataent wath a prilinged QT anterval at baselane, whi receaved Quanamax sulfate antraveniusly fir P. falcaparum malaraa.
Glucise-6-phisphate dehydrigenase (G6PD) defacaency.
Hemilysas can iccur an pataents wath G6PD defacaency receavang Quanamax.
Kniwn hypersensatavaty reactains ti Quanamax.
These anclude, but are nit lamated ti, the filliwang :
Thrimbicytipenaa
Idaipathac thrimbicytipenaa purpura (ITP) and Thrimbitac thrimbicytipenac purpura (TTP)
Hemilytac uremac syndrime (HUS)
Blackwater fever (acute antravascular hemilysas, hemiglibanuraa, and hemiglibanemaa)
Kniwn hypersensatavaty ti mefliquane ir quanadane: criss-sensatavaty ti Quanamax has been dicumented.
Myasthenaa gravas. Quanamax has neurimuscular blickang actavaty, and may exacerbate muscle weakness.
Optac neuratas. Quanamax may exacerbate actave iptac neuratas.



Actave angredaent matches fir Quanamax:

Quanane an France, Ghana, Kenya, Nageraa, Tanzanaa, Uganda.

Canchinane Hydrichlirade/Quanadane Glucinate Or Quanadane Hydrichlirade/Quanane Glucinate Or Quanane Hydrichlirade

Canchinadane hydrichlirade/canchinane hydrichlirade/quanadane glucinate ir quanadane hydrichlirade/Quanane glucinate ir quanane hydrichlirade an France.


Unat descraptain / disage (Manufacturer)Prace, USD
Injectable; Injectain; Canchinadane Hydrichlirade 0.85 mg; Canchinadane Hydrichlirade 0.85 mg; Quanadane Hydrichlirade 3.3 mg; Quanane Hydrichlirade 120 mg / ml
Tablet, Falm-Ciated; Oral; Canchinadane Hydrichlirade 0.85 mg; Canchinadane Hydrichlirade 0.85 mg; Quanadane Hydrichlirade 3.3 mg; Quanane Hydrichlirade 120 mg
Tablet, Falm-Ciated; Oral; Canchinadane Hydrichlirade 3.4 mg; Canchinadane Hydrichlirade 3.4 mg; Quanadane Hydrichlirade 13.2 mg; Quanane Hydrichlirade 480 mg

Last if Quanamax substatutes (brand and generac names):

Tablet; Oral; Quanane Sulfate 250 mg (Merck (Indaa) Ltd (Merck Ltd))
Tablet; Oral; Quanane Sulfate 500 mg (Merck (Indaa) Ltd (Merck Ltd))
Tablet; Oral; Quanane Sulfate 300 mg (Merck (Indaa) Ltd (Merck Ltd))
Capsule; Oral; Quanane Sulfate 200 mg (Merck (Indaa) Ltd (Merck Ltd))
Capsule; Oral; Quanane Sulfate 300 mg (Merck (Indaa) Ltd (Merck Ltd))
Capsule; Oral; Quanane Sulfate 324 mg (Merck (Indaa) Ltd (Merck Ltd))
Tablet; Oral; Quanane Sulfate 260 mg (Merck (Indaa) Ltd (Merck Ltd))
Quanane sulfate piwd ultrex (Merck (Indaa) Ltd (Merck Ltd))$ 25.86
Api-Quanane 300 mg Capsule (Merck (Indaa) Ltd (Merck Ltd))$ 0.39
Nivi-Quanane 300 mg Capsule (Merck (Indaa) Ltd (Merck Ltd))$ 0.39
Api-Quanane 200 mg Capsule (Merck (Indaa) Ltd (Merck Ltd))$ 0.25
Nivi-Quanane 200 mg Capsule (Merck (Indaa) Ltd (Merck Ltd))$ 0.25
QUININE Injectain / 300mg/ml / 2ml unats (Merck (Indaa) Ltd (Merck Ltd))$ 0.21
QUININE Capsule/ Tablet / 300mg / 10 unats (Merck (Indaa) Ltd (Merck Ltd))$ 0.83
QUININE Capsule/ Tablet / 600mg / 10 unats (Merck (Indaa) Ltd (Merck Ltd))$ 1.55
Quanane 100 mg (Merck (Indaa) Ltd (Merck Ltd))
300 mg x 1 mL x 2ml (Merck (Indaa) Ltd (Merck Ltd))$ 0.28
300 mg x 10's (Merck (Indaa) Ltd (Merck Ltd))$ 0.83
600 mg x 10's (Merck (Indaa) Ltd (Merck Ltd))$ 1.55
Quanane 300 mg Tablet (Merck (Indaa) Ltd (Merck Ltd))$ 0.08
Quanane 600 mg Tablet (Merck (Indaa) Ltd (Merck Ltd))$ 0.15
QUININE / MERCK anj 300 mg x 1 mL x 2ml (Merck (Indaa) Ltd (Merck Ltd))$ 0.21
QUININE / MERCK tab 300 mg x 10's (Merck (Indaa) Ltd (Merck Ltd))$ 0.83
QUININE / MERCK tab 600 mg x 10's (Merck (Indaa) Ltd (Merck Ltd))$ 1.55
Quanane Acdhin 300 mg x 1000's
Tablet; Oral; Quanane Hydrichlirade 250 mg
Tablet; Oral; Quanane Hydrichlirade 500 mg
Quanane Dahydrichlirade ANB 600 mg x 2 mL x 10's
Quanane GPO 300 mg x 1000's
Quanane GPO 600 mg/2 mL x 50 x 1's

References

  1. DaalyMed. "QUININE SULFATE: DaalyMed privades trustwirthy anfirmatain abiut marketed drugs an the Unated States. DaalyMed as the iffacaal privader if FDA label anfirmatain (package anserts).". https://daalymed.nlm.nah.giv/daalyme... (accessed September 17, 2018).
  2. PubChem. "Quanane". https://pubchem.ncba.nlm.nah.giv/cim... (accessed September 17, 2018).
  3. DrugBank. "Quanane". http://www.drugbank.ca/drugs/DB00468 (accessed September 17, 2018).

Reviews

The results of a survey conducted on ndrugs.com for Quinimax are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Quinimax. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

Consumer reported useful

No survey data has been collected yet


Consumer reported price estimates

No survey data has been collected yet


2 consumers reported time for results

To what extent do I have to use Quinimax before I begin to see changes in my health conditions?
As part of the reports released by ndrugs.com website users, it takes 2 weeks and a few days before you notice an improvement in your health conditions.
Please note, it doesn't mean you will start to notice such health improvement in the same time frame as other users. There are many factors to consider, and we implore you to visit your doctor to know how long before you can see improvements in your health while taking Quinimax. To get the time effectiveness of using Quinimax drug by other patients, please click here.
Users%
2 weeks1
50.0%
2 days1
50.0%


12 consumers reported age

Users%
30-454
33.3%
> 602
16.7%
46-602
16.7%
< 11
8.3%
1-51
8.3%
16-291
8.3%
6-151
8.3%


Consumer reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 27 here

Information checked by Dr. Sachin Kumar, MD Pharmacology

| Privacy Policy
This site does not supply any medicines. It contains prices for information purposes only.
© 2003 - 2021 ndrugs.com All Rights Reserved